PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVITA Medical, Inc. (RCEL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS05380C1027
CUSIP05380C102
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$213.11M
EPS-$1.40
Revenue (TTM)$50.14M
Gross Profit (TTM)$28.38M
EBITDA (TTM)-$41.94M
Year Range$7.97 - $21.70
Target Price$25.80
Short %6.17%
Short Ratio4.71

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AVITA Medical, Inc.

Popular comparisons: RCEL vs. ORI, RCEL vs. O

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AVITA Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%150.00%200.00%250.00%300.00%December2024FebruaryMarchAprilMay
87.97%
278.27%
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

AVITA Medical, Inc. had a return of -40.23% year-to-date (YTD) and -32.51% in the last 12 months. Over the past 10 years, AVITA Medical, Inc. had an annualized return of -2.77%, while the S&P 500 had an annualized return of 10.97%, indicating that AVITA Medical, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-40.23%11.29%
1 month-13.32%4.87%
6 months-36.53%17.88%
1 year-32.51%29.16%
5 years (annualized)-24.08%13.20%
10 years (annualized)-2.77%10.97%

Monthly Returns

The table below presents the monthly returns of RCEL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202422.16%8.17%-11.58%-47.60%-40.23%
202341.52%43.58%4.18%11.10%-26.42%48.95%19.05%-19.51%-10.37%-36.28%14.50%28.71%107.88%
2022-19.28%-4.86%-7.83%-28.07%-6.56%-16.67%18.53%9.77%-14.72%-7.21%35.99%-0.75%-44.91%
202132.88%-11.95%-8.83%4.14%-12.50%13.62%-9.70%9.07%-12.32%-7.05%-16.45%-12.94%-35.52%
2020-6.04%-10.06%-19.38%-2.26%6.27%-5.16%-28.72%17.73%-1.83%-18.60%5.57%-14.06%-59.16%
201967.86%7.98%107.88%24.41%12.38%4.92%-6.30%2.76%32.38%4.82%3.75%6.06%712.50%
2018-9.35%-5.15%2.17%-3.19%-6.59%25.88%14.95%17.89%11.72%-15.43%-10.95%-8.20%4.67%
2017-6.52%2.33%-9.09%-14.37%-6.57%-3.91%8.94%-17.16%-6.31%-16.35%16.09%5.94%-41.85%
20166.08%-5.73%10.81%32.93%-25.69%-9.88%0.68%-0.68%6.16%25.81%5.13%-10.24%24.32%
20153.23%-5.47%3.31%-4.00%2.50%5.69%-3.85%-8.00%16.52%16.42%-8.33%3.50%19.35%
2014-7.81%-5.08%-1.34%-3.62%0.00%-7.98%4.59%-6.34%-10.94%8.19%-15.14%-21.02%-51.56%
20136.00%0.75%-6.37%-20.00%1.00%26.24%-3.92%-2.45%-1.67%-9.36%-11.74%36.17%2.40%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RCEL is 23, indicating that it is in the bottom 23% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of RCEL is 2323
RCEL (AVITA Medical, Inc.)
The Sharpe Ratio Rank of RCEL is 2222Sharpe Ratio Rank
The Sortino Ratio Rank of RCEL is 2626Sortino Ratio Rank
The Omega Ratio Rank of RCEL is 2525Omega Ratio Rank
The Calmar Ratio Rank of RCEL is 2121Calmar Ratio Rank
The Martin Ratio Rank of RCEL is 1919Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AVITA Medical, Inc. (RCEL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


RCEL
Sharpe ratio
The chart of Sharpe ratio for RCEL, currently valued at -0.47, compared to the broader market-2.00-1.000.001.002.003.004.00-0.47
Sortino ratio
The chart of Sortino ratio for RCEL, currently valued at -0.25, compared to the broader market-4.00-2.000.002.004.006.00-0.25
Omega ratio
The chart of Omega ratio for RCEL, currently valued at 0.96, compared to the broader market0.501.001.502.000.96
Calmar ratio
The chart of Calmar ratio for RCEL, currently valued at -0.41, compared to the broader market0.002.004.006.00-0.41
Martin ratio
The chart of Martin ratio for RCEL, currently valued at -1.06, compared to the broader market-10.000.0010.0020.0030.00-1.06
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.44, compared to the broader market-2.00-1.000.001.002.003.004.002.44
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.45, compared to the broader market-4.00-2.000.002.004.006.003.45
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.42, compared to the broader market0.501.001.502.001.42
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.98, compared to the broader market0.002.004.006.001.98
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.39, compared to the broader market-10.000.0010.0020.0030.009.39

Sharpe Ratio

The current AVITA Medical, Inc. Sharpe ratio is -0.47. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AVITA Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.47
2.44
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


AVITA Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-85.14%
0
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AVITA Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AVITA Medical, Inc. was 91.79%, occurring on Oct 14, 2022. The portfolio has not yet recovered.

The current AVITA Medical, Inc. drawdown is 85.14%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.79%Feb 20, 2020670Oct 14, 2022
-85.27%May 18, 20121501May 7, 2018231Apr 8, 20191732
-36.33%Apr 9, 201982Aug 5, 201931Sep 18, 2019113
-26.8%Nov 13, 20197Nov 21, 201935Jan 14, 202042
-25.57%Apr 20, 201211May 8, 20124May 14, 201215

Volatility

Volatility Chart

The current AVITA Medical, Inc. volatility is 16.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%December2024FebruaryMarchAprilMay
16.90%
3.47%
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AVITA Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items